Zealand Pharma A/S (ZEAL) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Zealand Pharma A/S (ZEAL) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of Dkr8.51 Billion represents 1% of operating cash flow (Dkr8.52 Billion). Read ZEAL current and long-term liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

Dkr8.51 Billion

DKK

Operating Cash Flow

Dkr8.52 Billion

DKK

Capital Expenditures

Dkr6.73 Million

DKK

Zealand Pharma A/S Free Cash Flow Generation Index (2012–2025)

Historical FCF Generation Index trend for Zealand Pharma A/S across 3 annual periods. Explore ZEAL capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Zealand Pharma A/S (2012–2025)

Year-by-year Free Cash Flow Generation Index for Zealand Pharma A/S. For the full company profile including market capitalisation, see ZEAL stock market capitalisation.

Year	FCG Index	Free Cash Flow (DKK)	Operating CF	Capital Expenditures	YoY Change
2025	0.99x	Dkr6.50 Billion	Dkr6.53 Billion	Dkr33.37 Million	▲ +6.2%
2016	0.94x	Dkr38.30 Million	Dkr40.90 Million	Dkr2.60 Million	▲ +7.5%
2012	0.87x	Dkr59.69 Million	Dkr68.54 Million	Dkr8.85 Million	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).